Major Review Of EU Pharmaceutical Legislation Kicks Off
Roadmap Published As Part Of EU Pharma Strategy
Executive Summary
The European Commission has launched the process for reshaping and addressing the long-standing weakness in the EU’s pharmaceutical legislation. It has listed in a roadmap the issues it wants to address as it considers policy options for reforms.
You may also be interested in...
Commission Report Proposes Solutions To European Shortages
A European Commission study into the root causes of medicines shortages has identified a range of potential solutions, with the Commission identifying older, off-patent and generic drugs as the most at-risk.
European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform
The incentives system, access to medicines, future proofing for novel products and antimicrobial resistance are just some of the topics included in a new consultation.
EU Regulator Raises Possibility Of Shorter Drug Approval Timelines
With the EU pharmaceutical legislation due to undergo a radical shake-up to create a future-proof regulatory system, the time is ripe for industry to engage with efforts to make the European drug approval process more agile.